Impact of fremanezumab on response rates, acute medication use, and disability in patients with episodic migraine who have failed at least one prior migraine preventive medication

被引：0
作者：
Winner, Paul K. [1 ]
Singh, Rashmi B. Halker [2 ]
Cohen, Joshua M. [3 ]
Yang, Ronghua [3 ]
Yeung, Paul P. [3 ]
Ramirez Campos, Verena [4 ]
机构：
[1] Premiere Res Inst, W Palm Beach, FL USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Teva Pharmaceut, Frazer, PA USA
[4] Teva Pharmaceut, Buenos Aires, DF, Argentina
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O38
引用
收藏
页数：1
相关论文
共 50 条
[41]   Efficacy of Fremanezumab in Migraine Patients With Pain or Psychiatric Comorbidities and Documented Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes [J].
Spierings, E. L. H. ;
Ning, X. ;
Cohen, J. M. ;
Campos, V. Ramirez ;
Barash, S. .
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1) :18-18
[42]   Efficacy of Fremanezumab in Migraine Patients With Pain or Psychiatric Comorbidities and Documented Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes [J].
Spierings, E. L. H. ;
Ning, X. ;
Cohen, J. M. ;
Campos, V. Ramirez ;
Barash, S. .
CEPHALALGIA, 2021, 41 (1_SUPPL) :26-27
[43]   THE IMPACT OF FREMANEZUMAB ON MIGRAINE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN CHRONIC MIGRAINE PATIENTS WITH CONCOMITANT PREVENTIVE MEDICATION USE [J].
Lipton, R. B. ;
Fitzgerald, T. ;
Cohen, J. M. ;
Gandhi, S. K. .
CEPHALALGIA, 2018, 38 :95-96
[44]   The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Chronic Migraine Patients With Concomitant Preventive Medication Use [J].
Gandhi, Sanjay ;
Lipton, Richard ;
Cohen, Joshua .
NEUROLOGY, 2019, 92 (15)
[45]   Number Needed to Treat/Harm for Fremanezumab in Patients Who Had Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes [J].
Ashina, Messoud ;
Cohen, Joshua M. ;
Galic, Maja ;
Campos, Verena Ramirez ;
Du, Evelyn ;
Ning, Xiaoping ;
Diener, Hans-Christoph .
NEUROLOGY, 2021, 96 (15)
[46]   NUMBER NEEDED TO TREAT/HARM FOR FREMANEZUMAB IN PATIENTS WHO HAD INADEQUATE RESPONSE TO 2-4 PRIOR MIGRAINE PREVENTIVE MEDICATION CLASSES [J].
Ashina, Messoud ;
Cohen, Joshua M. ;
Galic, Maja ;
Campos, Verena Ramirez ;
Du, Evelyn ;
Ning, Xiaoping ;
Diener, Hans-Christoph .
CEPHALALGIA, 2020, 40 :102-102
[47]   Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine With Concomitant Preventive Medication Use [J].
Yeung, Paul ;
Goadsby, Peter ;
Jann, Adelene ;
Cohen, Joshua ;
Yang, Ronghua ;
Ning, Xiaoping .
NEUROLOGY, 2019, 92 (15)
[48]   Long-term Efficacy of Erenumab in Patients With Episodic Migranie Who Have Failed Prior Preventive Migraine Therapies [J].
Reuter, Uwe ;
Schwedt, Todd J. ;
Kudrow, David ;
Paemeleire, Koen ;
Zhang, Feng ;
Klatt, Jan ;
Picard, Hernan ;
Chou, Denise E. ;
Mikol, Daniel D. .
NEUROLOGY, 2019, 92 (15)
[49]   Impact of fremanezumab on any acute headache medication use in migraine patients with medication overuse and documented inadequate response to 2-4 migraine preventive medications in the multicentre, randomised, placebo-controlled FOCUS study [J].
Newman, Lawrence ;
Cohen, Joshua M. ;
Ramirez-Campos, Verena ;
Janka, Lindsay ;
Diener, Hans-Christoph .
CEPHALALGIA, 2019, 39 :238-238
[50]   Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine with Concomitant Preventive Medication Use [J].
Goadsby, P. J. ;
Jann, A. E. ;
Cohen, J. M. ;
Yang, R. ;
Ning, X. .
HEADACHE, 2019, 59 :117-118
12345